Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Nektar to Release 24-Week Off-Treatment Data for Rezpegaldesleukin in Alopecia Areata
3+ day, 18+ hour ago (323+ words) The Clinical Trial Vanguard Nektar to Release 24-Week Off-Treatment Data for Rezpegaldesleukin in Alopecia Areata Nektar Therapeutics went quiet on September 8, 2026, and will stay that way until it releases the 24-week off-treatment follow-up data from its Phase 2b REZOLVE-AA study of…...
QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy — TradingView News
4+ day, 4+ hour ago (75+ words) QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy TradingView QTTB: Phase II results support phase III advancement for a safe, effective alopecia areata therapy Positive phase II data for bempikibart in alopecia areata…...
Biotin Xtreme Hair Care Launches Natural Scalp Support Program for GLP-1 Hair Thinning - Send2Press Newswire
4+ day, 13+ hour ago (132+ words) Source: Biotin Xtreme Hair Care | Tue, 08 Sep 2026, 07:00:07 EDT UNDERSTANDING TELOGEN EFFLUVIUM & THE GLP-1 CONNECTION Unlike chemical topical solutions or prescription medications that may introduce unwanted systemic side effects, Biotin Xtreme’s program offers a 100% drug-free, hormone-free alternative that nourishes follicles directly…...
Best Minoxidil for Women (2026): Happy Head Recognized for Personalized Minoxidil Formulas by Consumer365
5+ day, 15+ hour ago (567+ words) NEW YORK, Sept. 7, 2026 /PRNewswire/ -- Consumer365 has named Happy Head its 2026 choice for personalized minoxidil formulas for women, examining how prescription hair-loss care can be adapted by age, medical history, hair-loss pattern, and preferred delivery method. Best Minoxidil for Women The report…...
Arthritis medication has been shown to be effective against alopecia, according to a study
5+ day, 11+ hour ago (331+ words) Upadacitinib, an anti-inflammatory drug used to treat arthritis, has been tested as a potential treatment for alopecia areata. An international team of researchers reported the results of two Phase III clinical trials in in a magazine JAMA Dermatology. A total…...
As hair loss treatments are attracting attention as a new investment destination on Wall Street foll.. - MK
5+ day, 19+ hour ago (271+ words) As hair loss treatments are attracting attention as a new investment destination on Wall Street following obesity treatments, "hair loss stocks" are also soaring in the domestic stock market. The JW new drug, which makes hair loss treatments for the…...
Hair-loss drugs are Wall Street’s next Ozempic-like bet. But what’s new in the science
1+ week, 3+ day ago (1144+ words) New Delhi: Hair-loss drugs are growing quickly into Wall Street’s latest big bet, but the excitement may have more to do with the size of the market and the opportunity it offers rather than an Ozempic-like scientific breakthrough, medical experts…...
Wall Street is on the lookout for the next breakthrough in hair loss treatments
2+ week, 11+ hour ago (698+ words) Cosmo is preparing a submission for the drug clascoterone in the US for the first quarter of 2027; Jefferies estimates its potential global sales at $3 billion, provided a partner is found. Investors are actively re-evaluating companies developing new treatments for hair…...
Forget GLP-1 stocks, baldness drugs are Wall Street???s next goldmine
2+ week, 10+ hour ago (603+ words) Drugmakers found a promising cure for the obesity epidemic and their stocks were rewarded for it. Now, investors are salivating over a new crop of companies tackling a more purely aesthetic problem: baldness. “People will fly all the way to…...
Upadacitinib Restored Substantial Scalp Hair in Severe Alopecia Areata, but Long-Term Safety and Durability Remain Unclear
2+ week, 20+ hour ago (1449+ words) Two Phase 3 trials involving 1,399 adults and adolescents found substantial scalp, eyebrow, and eyelash regrowth with upadacitinib after 24 weeks. The results are promising, but long-term safety, durability, and FDA approval for alopecia areata remain unresolved. Two randomized Phase 3 trials found that…...